YOU need to know about checkpoint inhibitors for immune surveillance to treat melanoma and other cancers. Immune mediated adverse events presented at this mtg range from 7 ~70% depending on drug, pts, Cancer. Rx with 2 inhibitors increases risk. MSk problems 2% #ACR18 @RheumNow

patients underoing lung transplant for ILD in rheumatic disease have similar long-term survival rates compared to those transplanted for IPF, abstract #2974 @RheumNow #ACR18

In #SystemicSclerosis, presence of higher #antivinculin antibodies (Ab against a cytoskeletal protein, also seen in IBS) was found among pts w more severe #scleroderma related GI disease. Was also assoc with scleroderma PAH/vasculopathy. Abstract 2937Dr. Suliman #ACR18 @RheumNow

#ACR18 #2925 - Fascinating study by Xenofon Baraliakos: vertebral fatty lesions (defined by MRI) in AS biopsied at spinal surgery. Confirms that fatty lesions indeed contain fat (in contrast to degen discs). Adipocytes seem to favour osteoblast activity. @RheumNow https://t.co/m2h6tvCwQQ

incidence of hypogam with rituximab is low but progressively identified overtime. infection rates remain low. abstract #2971 @RheumNow #ACR18

Check out Dr. Dao's coverage of the #ACR18 meeting as well as her other blogs on https://t.co/X7Lh9aCbYf. https://t.co/G7jWZ335SR

• http://acr18.rheumnow.com
• k dao on Twitter quotThx everyone for following me at this great acr18 meeting …

#IgG4 RD: bilateral lacrimal gland enlargement can occur in IgG4-RD, GPA, Sjögren syndrome. #ACR18 @RheumNow

Subset SSc with skin DcSSc and LcSSc and antibodies to be highly predictive for organ complications. Subsets in SSc are being updated for prognosis Abst2935 #ACR18 #GameChanger @RheumNow https://t.co/ZKFDwLBs96

#IgG4 RD: believed that IgG4 is not the causative agent, but rather goes into affected organs in order to downregulate an immune response. #ACR18 @RheumNow

#pseudoobstruction of the #GItract in #SystemicSclerosis was assoc with older age, diffuse skin dz, #myopathy, U3RNP, and opiod use. Abstract2939 Dr. Eric Dein. Opiod use a potentially modifiable risk factor. #ACR18 @RheumNow

new SLE classification criteria have been validated. need to know for clinical research and (re)certification of exams. #ACR18 @RheumNow https://t.co/1ld3yrOlE1

Interesting to note when interpreting data @rheumnow #acr18 https://t.co/zuvBSefHC3

• Juan Ovalles MD PhD on Twitter quotAlthough translational and clinicalepidemiol…

RheumNow expanded twitter coverage of the ACR 2018 Annual meeting sponsored in part by Horizon Pharma. All content chosen and distributed by RheumNow and its faculty.

J Olin: Segmental arterial mediolysis can mimic FMD. Characteristics: 1.noninflammatory, 2.nonatherosclerotic, 3.intraabdominal, 4.aneurysm/dissection 5. hemorrhagic. Dx:REQUIRES tissue examination. @rheumnow #acr18 https://t.co/kvFwRAeqRH